|
Arthritic problems are common. There are two major types of arthritis -- osteoarthritis and rheumatoid arthritis. Osteoarthritis is universal as we age. It afflicts the joints used most heavily during our lives and also is noted in joints that have been injured. In addition there is a family inheritance in some families. With time, the involved joints lose cartilage and develop some bone overgrowth. Redness and warmth are absent and the ability to perform the activities of daily life is usually preserved. Some joints are so painful from loss of cartilage that joint replacement may be needed. Rheumatoid arthritis afflicts three per cent of the population. Women are three times more likely to contract the illness than men. This illness often begins in younger women (age 20 to 40). The joints involved are usually symmetrical, and the involved joints develop swelling, redness, warmth, and pain. With time these joints often become very deformed and less functional. Severe deformity and or pain may require joint replacement. The traditional treatments for rheumatoid arthritis have serious problems. Cetyl myristolate CM is a medium chain fatty acid found in Swiss albino mice. Severe cases of rheumatoid arthritis are treated with cortisone gold injections, penicillamine, plaquenil, and chemotherapy drugs. Occasionally, a patient will have serious side-effects from these therapies. Osteoarthritis is usually treated with a variety of non-steroidal anti-inflammatory drugs (NSAIDs) including Anaprox, Aspirin, Celebrex, Clonoril, Feldene, Indocin, Lodine, Motrin, Relafen, Vioxx, etc. All these drugs can cause gastrointestinal bleeding with ulcerations. We recommend Cetyl Myristolate. | Click here to view product details >>
Among the successful treatments for arthritis is Cetyl Myristolate (CM). This intriguing substance was discovered by Dr. Harry Diehl while working at the National Institute of Health. Subsequent investigation of CM in patients disclosed that CM was beneficial in helping rheumatoid arthritis and osteoarthritis. Benefits are reported in the following conditions:
Cetyl myristolate appears to be a major breakthrough in the therapy of many diseases. Currently CM seems to be the only effective therapy for emphysema and temporomandibular joint syndrome. Those with arthritis are sometimes improved after 30 days of CM. Surprisingly, many of these patients do not need any further treatment. |
|


